Antithrombotic coating with sheltered positive charges prevents contact activation by controlling factor XII-biointerface binding
{{output}}
Antithrombotic surfaces that prevent coagulation activation without interfering with haemostasis are required for blood-contacting devices. Such materials would restrain device-induced thrombogenesis and decrease the need for anticoagulant use, thereby reducin... ...
